Insight and Intelligence on the London & International Insurance Markets 19 Feb 2018
Drug maker Valeant sues insurers for more than $325mn
- 23 January 2018
Canadian pharmaceutical company Valeant is suing its insurers as it seeks to claw back more than $325mn in costs, as well as unspecified damages, arising from class actions following its attempted acquisition of drug firm Allergan.
Court documents filed by Valeant in the Superior Court of New Jersey show it held professional indemnity policies for 2013-14 and 2015-16, with cover provided by Lloyd's syndicates and company market insurers.
The parties initiated mediation at the end of November but Valeant filed...
- If you are a non-subscriber but would like to be able to view this article, then please go to our Publications page for further information on joining our readership
- Login Free trial